Skip to Main Content

Kasia Lipska, MD, MHS, BS

Associate Professor of Medicine
DownloadHi-Res Photo

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Additional Titles

Affiliated Faculty, Yale Institute for Global Health

About

Titles

Associate Professor of Medicine

Affiliated Faculty, Yale Institute for Global Health

Biography

Dr. Lipska is an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). Her research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. Her current research projects are primarily focused on severe hypoglycemia. She is investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, she seeks to develop and implement decision support tools to help clinicians and patients make better decisions about their care. Her overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.

In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.

YCCI Scholar 2013

Project: 11/01/13 - 10/31/15

Treatment-Related Determinants of SevereHypoglycemia in Type 2 Diabetes

Appointments

  • Endocrinology

    Associate Professor on Term
    Primary

Other Departments & Organizations

Education & Training

Fogarty International Clinical Research Fellowship
Public Health Foundation of India (2012)
MHS
Yale University School of Medicine, Robert Wood Johnson Clinical Scholars Program (2011)
Fellowship
Yale University School of Medicine (2009)
Residency
Brigham and Women's Hospital (2006)
MD
Harvard Medical School (2003)
BS
Yale University, Molecular Biochemistry and Biophysics (1997)

Research

Overview

Medical Research Interests

Aging; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Costs; Endocrinology; Global Health; Hypoglycemia; India; Insulin; Multiple Chronic Conditions

Research at a Glance

Yale Co-Authors

Frequent collaborators of Kasia Lipska's published research.

Publications

2024

2023

Academic Achievements & Community Involvement

  • activity

    Endocrine Section Gender Equity Committee

  • activity

    Diabetes Care in Older Adults

  • activity

    National Public Radio, The People's Pharmacy, "How is diabetes diagnosed and treated"

  • activity

    The Insulin Racket – Why Is A Century-Old Drug Still So Expensive and What Can We Do About It?

  • activity

    Diabetes Management on a Budget

Clinical Care

Overview

Kasia J. Lipska, MD, MHS, is a diabetes expert who encourages her patients to take an active role in managing diabetes so they can live their lives as normally as possible. “We've come a long way to make the treatment of diabetes more effective, safer and easier to incorporate into everyday life,” she says. “I want the management of diabetes to be thoughtful, safe and kind.”

An assistant professor of medicine (endocrinology) at Yale School of Medicine, Dr. Lipska is also investigating ways to better manage type 2 diabetes, especially for older patients with multiple chronic ailments. Her primary research is on prevention of severe hypoglycemia, and on better understanding the pros and cons of glucose-lowering therapy in older adults.

An outspoken advocate for people with diabetes, Dr. Lipska published an opinion article in The New York Times in 2016 accusing drug companies and middle men of artificially inflating the price of insulin, which people with diabetes depend on to lower their blood sugar and keep them healthy. She also successfully petitioned federal regulators to allow expanded use of the drug metformin to treat type 2 diabetes.

Clinical Specialties

Internal Medicine; Endocrinology; Diabetes Medicine & Management

Fact Sheets

Board Certifications

  • Endocrinology Diabetes & Metabolism

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2009

Yale Medicine News

Get In Touch

Contacts

Appointment Number
Clinic Fax Number

Locations

  • Patient Care Locations

    Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

Events

Jan 20252Thursday
Jan 202516Thursday
Jan 202530Thursday
Feb 20256Thursday